Derma Pen v. 4EverYoung Limited et al
Filing
451
MEMORANDUM DECISION AND ORDER granting in part 141 Motion for TRO, 141 Motion for Preliminary Injunction - ruling is reserved on the balance of relief sought; Motion Hearing re 141 MOTION for Preliminary Injunction set for 1/6/2015 at 09:00 AM in Rm 3.100 before Judge David Nuffer. This order shall dissolve unless Defendants post security in the amount of $10,000 on or before 12/29/14. Signed by Judge David Nuffer on 12/23/14 (alt)
IN THE UNITED STATES DISTRICT COURT
DISTRICT OF UTAH, CENTRAL DIVISION
DERMA PEN, LLC,
Plaintiff,
v.
MEMORANDUM DECISION AND
ORDER GRANTING IN PART
DEFENDANTS’ MOTION FOR
TEMPORARY RESTRAINING ORDER
4EVERYOUNG LTD.,
DERMAPENWORLD, BIOSOFT (AUST)
PTY LTD d/b/a DERMAPENWORLD,
EQUIPMED INTERNATIONAL PTY.
LTD. d/b/a DERMAPENWORLD, and
STENE MARSHALL d/b/a
DERMAPENWORLD,
Defendants.
4EVERYOUNG LTD. and EQUIPMED
INTERNATIONAL PTY. LTD.,
Counterclaim Plaintiffs,
Case No.: 2:13-CV-00729-DN-EJF
v.
District Judge David Nuffer
DERMA PEN, LLC,
Magistrate Judge Evelyn J. Furse
Counterclaim Defendant.
Based upon Defendants’ Motion for Temporary Restraining Order and Preliminary
Injunction; 1 the December 23, 2014 telephonic conference; the prior orders, pleadings and papers
on file; and for good cause shown, the Court hereby FINDS and ORDERS as follows:
Derma Pen, LLC (“Derma Pen”) and 4EverYoung LTD (“4EverYoung”) have disputes
about the aftermath of a Distribution Agreement 2 they entered into in 2011, which terminated in
1
Docket No. 141, dated May 2, 2014.
2013. 4EverYoung claims it has the right to purchase a trademark and domain name controlled
by DermaPen. A two week jury trial on the most significant issues was set to begin August 11,
2014.
This litigation was interrupted by Derma Pen’s bankruptcy filing on August 8, 2014. 3
The bankruptcy case was dismissed December 19, 2014, because it was not filed in good faith,
on the finding that “the totality of the facts and circumstances of this case support a
determination that Derma Pen's bankruptcy petition was filed as a litigation tactic, rather than as
a good faith attempt to reorganize or preserve value for creditors.” 4 The bankruptcy court cited
an email sent from an affiliate of Derma Pen based on a conversation with Derma Pen's chief
executive officer, Jeremy Jones. The email stated that the Derma Pen “partners” were
transferring Derma Pen assets, including the trademark.
As a strategy in fighting this legal battle, the partners of Derma Pen, LLC
formed a new company, Medmetics, LLC, and have transferred most of the
assets of Derma Pen, LLC to this new entity, including the ownership of the
trademark. But it has been their intention for some time to abandon the
Derma Pen trademark and develop a new, uncontested trademark. 5
The bankruptcy court concluded that “Derma Pen's petition is an attempt to disrupt the
litigation process.” 6 The bankruptcy filing did accomplish that result.
Today, in a telephone conference to discuss the impact of the bankruptcy dismissal,
Derma Pen’s bankruptcy counsel stated that a Confession of Judgment was filed in Utah State
________________________
(...continued)
2
Sales Distribution Agreement [Sales Distribution Agreement], docket no. 25, filed October 10, 2013.
3
See In Re DermaPen, LLC, Bankr., case No. 14-11894 (KJC), docket nos. 273 and 274, filed December 19, 2014.
4
Memorandum at 17, docket no. 273, filed December 19, 2014, In Re DermaPen, LLC, Bankr., case No. 14-11894
(KJC).
5
Id. at 2.
6
Id. at 18.
2
Court yesterday, which was intended to result in surrender of the trademark and domain name,
subjects of this action, to Michael Anderer (“Anderer”), a principal in and allegedly a secured
creditor of Derma Pen. The Confession of Judgment 7 for nearly $800,000 recites that Anderer
holds an Amendment to Security Promissory Note and Security Agreement dated August 7,
2014. In today’s telephone conference, Derma Pen’s counsel in this litigation stated that they
were unaware of the Confession of Judgment or intended surrender. The surrender of Derma
Pen’s trademark and domain name to Anderer would interfere with the ability of this court to
grant relief to 4EverYoung by alienating those assets.
1.
On behalf of Derma Pen, Chad Milton signed the Distribution Agreement on July
28, 2011. 8
2.
On August 1 or 2, 2011, Marshall executed the Distribution Agreement on behalf
of 4EverYoung. 9
3.
Section 11.1 of the Distribution Agreement 10 provides as follows:
11.0 Term and Termination
11.1 Term.
The term of this Agreement shall be a two (2) year contract from the Effective
Date of this Agreement. It will renew automatically in one (1) year intervals,
except when notice of termination is provided by either party before 60 days of
the next renewal date.
4.
On May 30, 2013, Derma Pen sent notice, specifically invoking Section 11.1 of
the Distribution Agreement: 11
7
See Confession of Judgment, filed December 22, 2014, Michael E Anderer vs. Derma Pen LLC, case number
140908635, Third District Court, State of Utah.
8
Memorandum Decision and Order Granting 4EverYoung’s 238 Motion for Partial Summary Judgment on
Rescission [Rescission Summary Judgment] at 4, docket no. 397, filed August 4, 2014.
9
Id. at 5.
10
Sales Distribution Agreement § 11.
3
Mr. Marshall,
By this writing and pursuant to Section 11.1 of the Sales Distribution
Agreement between Derma Pen LLC and 4Ever Young Limited, Derma Pen
LLC hereby exercises its right to terminate the same Sales Distribution
Agreement with such termination becoming effective immediately upon the
expiration of the current term on August 1, 2013.
5.
The Distribution Agreement has been terminated. Derma Pen terminated it. 12
6.
Part of 4EverYoung’s claim for breach of contract 13 seeks specific performance
and damages under Distribution Agreement Sections 12.2 and 14.6. These clauses provide
4EverYoung with certain rights to purchase the Derma Pen US trademark and the dermapen.com
domain name after the Distribution Agreement terminated.
As part of acknowledging the Distributors ownership of the Derma Pen
Trademark in the US, The Distributor hereby acknowledges that should this
distribution agreement be terminated in accordance with Section 11, the
Distributor agrees to offer the Dermapen Trademark in the US for sale to 4EVER
YOUNG and 4EVER YOUNG has the first right of refusal for such trademark.
The Distributor and 4EVER YOUNG further agree that the value of the
Dermapen US Trademark will be determined by independent auditors of which
one will be appointed by both parties.
Should a satisfactory agreement on the price of the Dermapen US Trademark not
be obtained within 30 days from the appointment of each independent auditor,
both the Distributor and 4EVER YOUNG agree that the value will be determined
by the courts of the land that is governing this contract and their decision will be
final and binding upon both parties. 14
As part of acknowledging the Distributors ownership of the DermaPen.com
domain, The Distributor hereby acknowledges that should this distribution
agreement be terminated in accordance with Section 11, the Distributor agrees to
offer the Dermapen.com domain for sale to 4EVER YOUNG and 4EVER
YOUNG has the first right of refusal for such domain. The Distributor and
________________________
(...continued)
11
Rescission Summary Judgment at 6.
12
Id. at 11.
13
First Amended Counterclaim and Demand for Jury Trial, First Cause of Action ¶¶ 59-65 at 29-30, docket no. 215,
filed June 26, 2014.
14
Distribution Agreement § 12.2.
4
4EVER YOUNG further agree that the value of the Dermapen.com domain will
be determined by independent auditors of which one will be appointed by both
parties.
Should a satisfactory agreement on the price of the Dermapen.com domain not be
obtained within 30 days from the appointment of each independent auditor, both
the Distributor and 4EVER YOUNG agree that the value will be determined by
the courts of the land that is governing this contract and their decision will be
final and binding upon both parties. 15
7.
Derma Pen has consistently resisted 4EverYoung’s exercise of its rights under
Sections 12.2 and 14.6 of the Distribution Agreement.
8.
The bankruptcy dismissal declares that the bankruptcy filing was a bad faith
attempt to prevent adjudication in this case.
9.
The Confession of Judgment is also an attempt to evade this adjudication process
by placing the trademark beyond the reach of the court.
10.
Derma Pen’s counsel have filed motions to withdraw and claim they have been
instructed not to take further action on behalf of Derma Pen, making further hearing before
issuance of this order impossible in a time to prevent further attempts to transfer the properties
that are the subject of this litigation.
11.
Transfer of the domain name and trademark would interfere with the ability of
this court, in the event that relief is found to be appropriate, to require Derma Pen to offer to sell
the trademark and domain name to 4EverYoung in accordance with the Distribution Agreement,
15
Distribution Agreement § 14.6.
5
IT IS HEREBY ORDERED:
1.
Defendants’ Motion 16 for Temporary Restraining Order and Preliminary
Injunction is GRANTED IN PART and RULING IS RESERVED on the balance of relief
sought.
2.
Derma Pen, its officers, agents, servants, employees, and attorneys, and those
acting in concert, with them (collectively, the “Enjoined Parties”) shall not transfer the trademark
and domain name.
3.
This temporary restraining order will remain in effect until the conclusion of the
hearing on the Preliminary Injunction as to this relief, which is set to begin Tuesday January 6,
2015 at 9:00 a.m. Derma Pen’s failure to appear through counsel at this hearing will result in
entry of a preliminary injunction.
4.
This order shall dissolve unless Defendants post security in the amount of
$10,000 on or before December 29, 2014. The court is not open for business until that time.
DATED this 23rd day of December, 2014.
BY THE COURT
David Nuffer
United States District Judge
16
Docket No. 141, dated May 2, 2014.
6
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?